Banks - Regional
Build Your Comparison
Side-by-side financial analysisStock Comparison
SBFG vs ICE vs KO vs JPM vs CME
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Data & Stock Exchanges
Beverages - Non-Alcoholic
Banks - Diversified
Financial - Data & Stock Exchanges
SBFG vs ICE vs KO vs JPM vs CME — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Banks - Regional | Financial - Data & Stock Exchanges | Beverages - Non-Alcoholic | Banks - Diversified | Financial - Data & Stock Exchanges |
| Market Cap | $147M | $79.60B | $355.61B | $896.00B | $97.79B |
| Revenue (TTM) | $91M | $12.64B | $49.28B | $280.33B | $6.76B |
| Net Income (TTM) | $14M | $3.30B | $13.70B | $57.05B | $4.24B |
| Gross Margin | 70.6% | 61.9% | 61.7% | 60.0% | 86.3% |
| Operating Margin | 19.0% | 38.7% | 29.3% | 25.9% | 65.6% |
| Forward P/E | 9.4x | 17.3x | 25.3x | 14.4x | 22.0x |
| Total Debt | $74M | $20.28B | $45.49B | $942.38B | $3.76B |
| Cash & Equiv. | $72M | $837M | $10.27B | $343.34B | $4.42B |
SBFG vs ICE vs KO vs JPM vs CME — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| SB Financial Group,… (SBFG) | 100 | 147.3 | +47.3% |
| Intercontinental Ex… (ICE) | 100 | 153.4 | +53.4% |
| The Coca-Cola Compa… (KO) | 100 | 184.9 | +84.9% |
| JPMorgan Chase & Co. (JPM) | 100 | 341.0 | +241.0% |
| CME Group Inc. (CME) | 100 | 165.8 | +65.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SBFG vs ICE vs KO vs JPM vs CME
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SBFG carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 12 yrs, beta 0.64, yield 2.6%
- Rev growth 11.9%, EPS growth 27.3%
- Beta 0.64, yield 2.6%, current ratio 3.66x
- NIM 3.1% vs JPM's 2.2%
ICE ranks third and is worth considering specifically for sleep-well-at-night.
- Lower volatility, beta 0.35, Low D/E 69.9%, current ratio 1.02x
- Beta 0.35 vs JPM's 0.94, lower leverage
KO is the clearest fit if your priority is efficiency.
- 13.1% ROA vs SBFG's 0.9%, ROIC 15.8% vs 6.3%
JPM is the clearest fit if your priority is long-term compounding and valuation efficiency.
- 465.8% 10Y total return vs CME's 262.4%
- PEG 0.81 vs SBFG's 2.94
CME is the #2 pick in this set and the best alternative if quality and dividends is your priority.
- 62.8% margin vs SBFG's 15.4%
- 4.1% yield, 15-year raise streak, vs KO's 2.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 11.9% NII/revenue growth vs KO's 1.9% | |
| Value | Lower P/E (9.4x vs 22.0x) | |
| Quality / Margins | 62.8% margin vs SBFG's 15.4% | |
| Stability / Safety | Beta 0.35 vs JPM's 0.94, lower leverage | |
| Dividends | 4.1% yield, 15-year raise streak, vs KO's 2.5% | |
| Momentum (1Y) | +30.3% vs ICE's -20.4% | |
| Efficiency (ROA) | 13.1% ROA vs SBFG's 0.9%, ROIC 15.8% vs 6.3% |
SBFG vs ICE vs KO vs JPM vs CME — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
SBFG vs ICE vs KO vs JPM vs CME — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CME leads in 1 of 6 categories
SBFG leads 1 • KO leads 1 • JPM leads 1 • ICE leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CME leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 3079.7x SBFG's $91M. CME is the more profitable business, keeping 62.8% of every revenue dollar as net income compared to SBFG's 15.4%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $91M | $12.6B | $49.3B | $280.3B | $6.8B |
| EBITDAEarnings before interest/tax | $19M | $6.5B | $15.5B | $81.4B | $4.7B |
| Net IncomeAfter-tax profit | $14M | $3.3B | $13.7B | $57.0B | $4.2B |
| Free Cash FlowCash after capex | $20M | $4.3B | $12.6B | $100.9B | $4.4B |
| Gross MarginGross profit ÷ Revenue | +70.6% | +61.9% | +61.7% | +60.0% | +86.3% |
| Operating MarginEBIT ÷ Revenue | +19.0% | +38.7% | +29.3% | +25.9% | +65.6% |
| Net MarginNet income ÷ Revenue | +15.4% | +26.1% | +27.8% | +20.4% | +62.8% |
| FCF MarginFCF ÷ Revenue | +21.7% | +33.9% | +25.5% | +36.0% | +64.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | +12.1% | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +14.5% | +23.1% | +18.2% | +16.0% | +21.4% |
Valuation Metrics
SBFG leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 10.6x trailing earnings, SBFG trades at a 61% valuation discount to KO's 27.2x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.90x vs SBFG's 3.32x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $147M | $79.6B | $355.6B | $896.0B | $97.8B |
| Enterprise ValueMkt cap + debt − cash | $150M | $99.0B | $390.8B | $1.50T | $97.1B |
| Trailing P/EPrice ÷ TTM EPS | 10.64x | 24.36x | 27.18x | 16.00x | 24.15x |
| Forward P/EPrice ÷ next-FY EPS est. | 9.44x | 17.34x | 25.27x | 14.40x | 21.98x |
| PEG RatioP/E ÷ EPS growth rate | 3.32x | 2.74x | 2.43x | 0.90x | 1.76x |
| EV / EBITDAEnterprise value multiple | 7.69x | 15.34x | 26.39x | 18.36x | 21.56x |
| Price / SalesMarket cap ÷ Revenue | 1.61x | 6.30x | 7.42x | 3.20x | 15.00x |
| Price / BookPrice ÷ Book value/share | 1.05x | 2.77x | 10.40x | 2.47x | 3.38x |
| Price / FCFMarket cap ÷ FCF | 6.85x | 18.56x | 67.15x | 8.88x | 23.32x |
Profitability & Efficiency
KO leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
KO delivers a 41.1% return on equity — every $100 of shareholder capital generates $41 in annual profit, vs $10 for SBFG. CME carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), ICE scores 9/9 vs CME's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +10.3% | +11.6% | +41.1% | +15.9% | +15.3% |
| ROA (TTM)Return on assets | +0.9% | +2.3% | +13.1% | +1.3% | +2.2% |
| ROICReturn on invested capital | +6.3% | +7.5% | +15.8% | +4.5% | +10.2% |
| ROCEReturn on capital employed | +2.0% | +9.5% | +17.3% | +8.9% | +3.6% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 9 | 7 | 5 | 5 |
| Debt / EquityFinancial leverage | 0.53x | 0.70x | 1.33x | 2.60x | 0.13x |
| Net DebtTotal debt minus cash | $3M | $19.4B | $35.2B | $599.0B | -$666M |
| Cash & Equiv.Liquid assets | $72M | $837M | $10.3B | $343.3B | $4.4B |
| Total DebtShort + long-term debt | $74M | $20.3B | $45.5B | $942.4B | $3.8B |
| Interest CoverageEBIT ÷ Interest expense | 0.68x | 6.53x | 10.70x | 0.74x | 41.55x |
Total Returns (Dividends Reinvested)
JPM leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JPM five years ago would be worth $21,820 today (with dividends reinvested), compared to $13,085 for ICE. Over the past 12 months, SBFG leads with a +30.3% total return vs ICE's -20.4%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.6% vs ICE's 10.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +10.6% | -11.8% | +20.3% | -0.5% | +3.2% |
| 1-Year ReturnPast 12 months | +30.3% | -20.4% | +17.2% | +21.8% | +3.6% |
| 3-Year ReturnCumulative with dividends | +98.0% | +34.6% | +47.0% | +138.2% | +67.9% |
| 5-Year ReturnCumulative with dividends | +44.8% | +30.9% | +65.6% | +118.2% | +46.2% |
| 10-Year ReturnCumulative with dividends | +167.5% | +195.3% | +121.1% | +465.8% | +262.4% |
| CAGR (3Y)Annualised 3-year return | +25.6% | +10.4% | +13.7% | +33.6% | +18.9% |
Risk & Volatility
Evenly matched — KO and CME each lead in 1 of 2 comparable metrics.
Risk & Volatility
CME is the less volatile stock with a -0.28 beta — it tends to amplify market swings less than JPM's 0.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. KO currently trades 98.3% from its 52-week high vs ICE's 74.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.64x | 0.35x | -0.20x | 0.94x | -0.28x |
| 52-Week HighHighest price in past year | $23.93 | $189.35 | $84.04 | $337.25 | $329.16 |
| 52-Week LowLowest price in past year | $17.10 | $136.67 | $65.35 | $262.71 | $244.56 |
| % of 52W HighCurrent price vs 52-week peak | +97.4% | +74.2% | +98.3% | +95.1% | +81.9% |
| RSI (14)Momentum oscillator 0–100 | 60.2 | 31.9 | 60.6 | 59.1 | 40.1 |
| Avg Volume (50D)Average daily shares traded | 10K | 3.2M | 12.7M | 7.0M | 2.6M |
Analyst Outlook
Evenly matched — KO and CME each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: ICE as "Buy", KO as "Buy", JPM as "Buy", CME as "Hold". Consensus price targets imply 38.0% upside for ICE (target: $194) vs 4.2% for KO (target: $86). For income investors, CME offers the higher dividend yield at 4.05% vs ICE's 1.38%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | — | $194.00 | $86.13 | $339.75 | $320.80 |
| # AnalystsCovering analysts | — | 36 | 48 | 61 | 36 |
| Dividend YieldAnnual dividend ÷ price | +2.6% | +1.4% | +2.5% | +1.9% | +4.1% |
| Dividend StreakConsecutive years of raises | 12 | 13 | 56 | 15 | 15 |
| Dividend / ShareAnnual DPS | $0.60 | $1.93 | $2.04 | $5.95 | $10.92 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.9% | +1.7% | +0.2% | +3.9% | +0.3% |
CME leads in 1 of 6 categories (Income & Cash Flow). SBFG leads in 1 (Valuation Metrics). 2 tied.
SBFG vs ICE vs KO vs JPM vs CME: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SBFG or ICE or KO or JPM or CME a better buy right now?
For growth investors, SB Financial Group, Inc.
(SBFG) is the stronger pick with 11. 9% revenue growth year-over-year, versus 1. 9% for The Coca-Cola Company (KO). SB Financial Group, Inc. (SBFG) offers the better valuation at 10. 6x trailing P/E (9. 4x forward), making it the more compelling value choice. Analysts rate Intercontinental Exchange, Inc. (ICE) a "Buy" — based on 36 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SBFG or ICE or KO or JPM or CME?
On trailing P/E, SB Financial Group, Inc.
(SBFG) is the cheapest at 10. 6x versus The Coca-Cola Company at 27. 2x. On forward P/E, SB Financial Group, Inc. is actually cheaper at 9. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 81x versus SB Financial Group, Inc. 's 2. 94x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — SBFG or ICE or KO or JPM or CME?
Over the past 5 years, JPMorgan Chase & Co.
(JPM) delivered a total return of +118. 2%, compared to +30. 9% for Intercontinental Exchange, Inc. (ICE). Over 10 years, the gap is even starker: JPM returned +465. 8% versus KO's +121. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SBFG or ICE or KO or JPM or CME?
By beta (market sensitivity over 5 years), CME Group Inc.
(CME) is the lower-risk stock at -0. 28β versus JPMorgan Chase & Co. 's 0. 94β — meaning JPM is approximately -435% more volatile than CME relative to the S&P 500. On balance sheet safety, CME Group Inc. (CME) carries a lower debt/equity ratio of 13% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — SBFG or ICE or KO or JPM or CME?
By revenue growth (latest reported year), SB Financial Group, Inc.
(SBFG) is pulling ahead at 11. 9% versus 1. 9% for The Coca-Cola Company (KO). On earnings-per-share growth, the picture is similar: SB Financial Group, Inc. grew EPS 27. 3% year-over-year, compared to 1. 5% for JPMorgan Chase & Co.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SBFG or ICE or KO or JPM or CME?
CME Group Inc.
(CME) is the more profitable company, earning 62. 0% net margin versus 15. 4% for SB Financial Group, Inc. — meaning it keeps 62. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CME leads at 64. 9% versus 19. 0% for SBFG. At the gross margin level — before operating expenses — CME leads at 86. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SBFG or ICE or KO or JPM or CME more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 81x versus SB Financial Group, Inc. 's 2. 94x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, SB Financial Group, Inc. (SBFG) trades at 9. 4x forward P/E versus 25. 3x for The Coca-Cola Company — 15. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ICE: 38. 0% to $194. 00.
08Which pays a better dividend — SBFG or ICE or KO or JPM or CME?
All stocks in this comparison pay dividends.
CME Group Inc. (CME) offers the highest yield at 4. 1%, versus 1. 4% for Intercontinental Exchange, Inc. (ICE).
09Is SBFG or ICE or KO or JPM or CME better for a retirement portfolio?
For long-horizon retirement investors, CME Group Inc.
(CME) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 28), 4. 1% yield, +262. 4% 10Y return). Both have compounded well over 10 years (CME: +262. 4%, JPM: +465. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SBFG and ICE and KO and JPM and CME?
These companies operate in different sectors (SBFG (Financial Services) and ICE (Financial Services) and KO (Consumer Defensive) and JPM (Financial Services) and CME (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: SBFG is a small-cap deep-value stock; ICE is a mid-cap quality compounder stock; KO is a large-cap quality compounder stock; JPM is a large-cap deep-value stock; CME is a mid-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.